Neostrata Company, a leader in dermocosmetics, to be purchased by Johnson & Johnson Consumer Inc.
April 28, 2016
by Canadian Packaging staff
SKILLMAN, NJ—Johnson & Johnson Consumer Inc. has entered into a definitive agreement to acquire NeoStrata Company, Inc., a global leader in dermocosmetics.
The acquisition will include NeoStrata’s affiliates and parent company TriStrata, Incorporated, a privately-held company. Financial terms were not disclosed.
NeoStrata, based in Princeton, N.J., has a history of innovation that includes breakthrough research in Alpha hydroxy acids, which have become a standard among anti-aging technologies in the beauty category. The company develops and markets a range of clinically-proven, dermatologist-developed, skin care products that meet the needs of every skin type.
“Drs. Ruey Yu and Eugene Van Scott formed NeoStrata in 1988 and continue to make significant contributions to the science of skincare. NeoStrata’s legacy in dermocosmetics will complement our global Consumer portfolio and enable us to deliver advanced skin care brands to consumers around the world,” says Johnson & Johnson Consumer worldwide chairman Jorge Mesquita. “NeoStrata and Johnson & Johnson share a strong history of innovation and together we will work to discover important new skin care solutions grounded in deep human insights and compelling science. We look forward to working closely with NeoStrata’s distributors around the world and having their outstanding team of employees join Johnson & Johnson Consumer later this year.”
The acquisition is subject to clearance under the Hart-Scott-Rodino Antitrust Improvements Act and other customary closing conditions and expected to close in the first half of 2016.
About Johnson & Johnson Consumer Inc.
Johnson & Johnson Consumer Inc., based in Skillman, N.J., is one of the world’s largest consumer health and personal care products company. Its consumer companies produce many of the world’s most trusted brands, among them JOHNSON’S Baby, BAND-AID, NEUTROGENA, TYLENOL, MOTRIN, and LISTERINE. Further company information available at www.jnj.com.